Back to
BNP Paribas Financial Markets
BBIO
28 quarters
Position history for
BNP Paribas Financial Markets's holdings in BridgeBio Pharma, Inc.
Yes. BNP Paribas Financial Markets holds 1,155,442 shares of BBIO (BridgeBio Pharma), worth $86.1M, as of its Q2 2026 13F filing. It reduced the position by 151,734 shares (-11.6%) from Q1 2026. BNP Paribas Financial Markets has held BBIO since Q4 2022, across 15 quarterly 13F filings.
Current Value
$86.1M
Current Shares
1.2M
Total Value Change
+$86M
Total Shares Change
+1.2M
Quarter-by-Quarter History
Other major holders of BBIO: Viking Global Investors LP, Vanguard Group Inc.